Stay updated on BMN165 Self-Injections in PKU Clinical Trial
Sign up to get notified when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.

Latest updates to the BMN165 Self-Injections in PKU Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNone of the core study details (purpose, outcomes, eligibility criteria, or enrollment) appear to have changed; updates are limited to UI/metadata elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

- Check45 days agoChange DetectedNew version v3.1.0 added; several drug-safety topics were removed; prior version v3.0.2 remains referenced as a previous revision.SummaryDifference0.3%

- Check59 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive changes detected.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has updated its facility name and location to St. Louis, Missouri, and added new drug information regarding Pegvaliase, while removing some previous location details and specific drug categories.SummaryDifference2%

Stay in the know with updates to BMN165 Self-Injections in PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.